Quantitative monitoring of pluripotency gene activation after somatic cloning in cattle by Wuensch, Annegret et al.
BIOLOGY OF REPRODUCTION 76, 983–991 (2007)
Published online before print 21 February 2007.
DOI 10.1095/biolreprod.106.058776
Quantitative Monitoring of Pluripotency Gene Activation after Somatic Cloning in
Cattle1
Annegret Wuensch,3,4 Felix A. Habermann,3,5 Satoshi Kurosaka,6 Regina Klose,4 Valeri Zakhartchenko,4
Horst-Dieter Reichenbach,7 Fred Sinowatz,5 K. John McLaughlin,6 and Eckhard Wolf2,4,8
Institute of Molecular Animal Breeding and Biotechnology,4 Ludwig-Maximilians University, D-81377 Munich, Germany
Institute of Veterinary Anatomy, Histology and Embryology,5 Ludwig-Maximilians University, D-80539 Munich, Germany
Center for Animal Transgenesis and Germ Cell Research,6 The School of Veterinary Medicine, University of
Pennsylvania, Kennett Square, Pennsylvania 19348
Biotechnology Unit,7 Institute of Animal Breeding, Bavarian State Institute for Agriculture, D-85586 Poing, Germany
Laboratory for Functional Genome Analysis (LAFUGA),8 Gene Center, Ludwig-Maximilians University,
D-81377 Munich, Germany
ABSTRACT
The development of somatic cell nuclear transfer (SCNT)
embryos critically depends on appropriate reprogramming and
expression of pluripotency genes, such as Pou5f1/POU5F1
(previously known as Oct4/OCT4). To study POU5F1 transcrip-
tion activation in living bovine SCNT embryos without interfer-
ence by maternal POU5F1 mRNA, we generated chromosomally
normal fetal fibroblast donor cells stably carrying a mouse
Pou5f1 promoter-driven enhanced green fluorescent protein
(EGFP) reporter gene at a single integration site without
detectable EGFP expression. Morphologic and quantitative
analyses of whole-mount SCNT embryos by confocal microscopy
revealed robust initial activation of the Pou5f1 reporter gene
during the fourth cell cycle. In Day 6 SCNT embryos EGFP
expression levels were markedly higher than in Day 4 embryos
but varied substantially between individual embryos, even at
comparable cell numbers. Embryos with low EGFP levels had far
more morphologically abnormal cell nuclei than those with high
EGFP levels. Our data strongly suggest that bovine SCNT
embryos consistently start activation of the POU5F1 promoter
during the fourth cell cycle, whereas later in development the
expression level substantially differs between individual embry-
os, which may be associated with developmental potential. In
fibroblasts from phenotypically normal SCNT fetuses recovered
on Day 34, the Pou5f1 reporter promoter was silent but was
activated by a second round of SCNT. The restoration of
pluripotency can be directly observed in living cells or SCNT
embryos from such Pou5f1-EGFP transgenic fetuses, providing
an attractive model for systematic investigation of epigenetic
reprogramming in large mammals.
early development, embryo
INTRODUCTION
The generation of viable offspring by somatic cell nuclear
transfer (SCNT) demonstrated that nuclei of differentiated
mammalian somatic cells can be reprogrammed to totipotency
by transfer into an enucleated oocyte [1]. The efficiency of
animal cloning by SCNT varies considerably among the species
studied (reviewed in Shi et al. [2]). The highest success rates of
SCNT have been reported in cattle, and the total number of
cloned cattle worldwide has recently been estimated in the range
of several thousand animals (reviewed in Kues and Niemann
[3]). However, even in cattle only a small minority of SCNT
embryos develop into an apparently healthy animal, and a large
variety of pathologic abnormalities have been reported in
bovine SCNT fetuses and live- or dead-born offspring [4–10].
These abnormalities are assumed to originate from incomplete
or aberrant epigenetic reprogramming of the somatic donor cell
nucleus (reviewed in Shi et al. [2]). Recent studies described
abnormal DNA methylation and histone modification patterns
in cloned embryos and fetuses that were associated with
abnormal embryonic or fetal development [11–13].
Currently, expression of the transcription factor POU5F1
(POU domain, class 5, transcription factor 1; previously known
as OCT4) is regarded as the most valid marker for epigenetic
reprogramming and pluripotency (reviewed in Pesce and Schöler
[14]). There is ample evidence from studies in mice that POU5F1
protein is crucial for normal early embryonic development [15]
and for the maintenance of pluripotency in embryonic stem cells
[16]. Blastocysts from Pou5f1 knockout mice do not develop a
developmentally competent inner cell mass (ICM; [15]). The
cellular amount of POU5F1 protein was shown to crucially affect
the differentiation fate of mouse embryonic stem cells [16],
providing further substantial evidence that POU5F1 is a key
regulator of early embryonic cell differentiation. Moreover,
studies in mice have shown that successful reprogramming of a
somatic donor cell nucleus after SCNT critically depends on the
activation and adequate expression of the Pou5f1 gene: both
analysis of endogenous Pou5f1 mRNA expression [17] and
observation of the Pou5f1 promoter activity using an enhanced
green fluorescent protein (EGFP) reporter gene construct [18] led
to the suggestion that aberrant expression of the Pou5f1 gene
might be a major cause for impaired development of cloned
mouse embryos [18]. The Pou5f1-EGFP reporter construct
GOF18-DPE-EGFP containing 9 kb of promoter sequences of
the mouse Pou5f1 gene was shown to reflect the expression of the
endogenous Pou5f1 gene in transgenic mouse embryos [19].
Since the genomic organization and regulatory sequences are
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highly conserved between the mouse Pou5f1 gene and its bovine
and human orthologues [20, 21], it was assumed that the mouse
Pou5f1 promoter-driven EGFP reporter construct also should be
regulated properly in cattle and other mammals. After microin-
jection of the GOF18-DPE-EGFP reporter construct into bovine
and porcine zygotes, the resulting blastocysts from both species
showed EGFP expression, demonstrating functional conservation
of the Pou5f1 promoter region between mice and other
mammalian species [22]. However, the reporter gene expression
patterns observed after microinjection into zygotes were strongly
influenced by inconsistent and unstable integration and/or
mosaicism [22], and thus were difficult to interpret.
To create a strategic tool for reprogramming research in
large mammals we decided 1) to transfect bovine fetal
fibroblasts (BFFs) with the Pou5f1 reporter construct
GOF18-DPE-EGFP; 2) to use cell clones stably carrying the
construct at a single chromosome locus for SCNT; 3) to
analyze the expression of the Pou5f1-EGFP reporter gene
construct and the endogenous POU5F1 mRNA in SCNT
embryos at the temporal, spatial, and quantitative level; and 4)
to investigate the in vitro and in vivo developmental potency of
Pou5f1-EGFP transgenic SCNT embryos.
MATERIALS AND METHODS
Cell Culture and Transfection
All animal experiments were carried out according to the institutional rules
and with permission of the responsible veterinary authority.
Cattle were bred and raised at the Institute of Molecular Animal Breeding
and Biotechnology (Ludwig-Maximilians University). Fibroblasts from a Day
42 bovine fetus (BFF116) were cultured in Dulbecco modified Eagle medium
(DMEM; Invitrogen, Karlsruhe, Germany) supplemented with 10% (v/v) fetal
calf serum (PAA, Pasching, Austria), 293 mg/l L-glutamine, 100 U/ml
penicillin, 100 lg/ml streptomycin (PAA), 0.1 mM 2-mercaptoethanol, and
1% (v/v) nonessential amino acids (PAA). Cells were cultured at 378C in a
humidified atmosphere of 5% CO
2
in air.
The reporter gene construct GOF18-DPE-EGFP [22, 23] includes the EGFP
gene flanked by a 9-kb fragment of the murine Pou5f1 upstream region with a
deletion in the proximal enhancer (PE), and a 9-kb fragment containing the
nontranscribed murine structural Pou5f1 gene. The 21.2-kb fragment GOF18-
DPE-EGFP was released from the vector backbone by NotI digestion and was
purified with QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) after gel
electrophoresis.
BFF116 cells (5 3 105) were cotransfected with GOF18-DPE-EGFP and the
neomycin resistance cassette FRT-neo-FRT (kindly provided by Jessica Gorski
and Kevin R. Jones, University of Colorado at Boulder, Boulder, CO) by
electroporation in Human Dermal Fibroblast Nucleofector Solution (Amaxa,
Cologne, Germany) using the Nucleofector device (Amaxa) and program U23.
Three days after electroporation the cells were trypsinized and seeded in selection
medium (1.0 mg/ml G418) at 2000 cells/well in 96-well plates. Selection medium
was changed every other day. After 1 wk, resistant cell colonies were transferred
to replica plates for genotyping, karyotype and fluorescent in situ hybridization
(FISH) analysis, and cryopreservation. Bovine fetal fibroblasts that were
lentivirus transduced with a reporter gene driven by the PGK1 housekeeping
gene promoter [24] were used as a positive control for EGFP detection.
PCR Analysis of GOF18-DPE-EGFP Transgenic Cell Clones
(BFFGOF)
Genomic DNA of G418-resistant cell clones was extracted by digestion with
proteinase K (Roche, Mannheim, Germany). Primers used to detect the presence
of the reporter gene GOF18-DPE-EGFP were GOFGFP3 (forward) 50-
ccctaggtgagccgtctttcc-30 and GOFGFP4 (reverse) 50-ccttgatgccgttcttctgct-30.
Twenty-microliter reactions contained 2 ll of 103 PCR buffer (Qiagen), 4 ll
Q-solution (Qiagen), 1.25 ll MgCl
2
(25 mM), 1 ll dinucleotide triphosphates (1
mM), 1 ll primer (2 lM), and 0.1 ll Taq polymerase (5 U/ll; Qiagen). The
cycling conditions for PCR reactions were: 3 min at 948C, 35 cycles with 30 sec at
948C, 30 sec at 638C, 1 min at 728C, and 10 min at 728C for final extension.
Chromosome Analysis and FISH
Transgenic cell clones at passages 10–13 were harvested for karyotyping
and transgene integration analysis by FISH. Metaphase spreads were prepared
following standard protocols [25].
To generate a FISH probe specific for the reporter gene construct GOF18-
DPE-EGFP, 10 DNA fragments ranging in size from 500 to 724 bp and spanning
a total of ;5.7 kb (Fig. 1A) were amplified by PCR from plasmid DNA. Primers
were designed using Primer Express software (Applied Biosystems, Darmstadt,
Germany). The transgene-specific DNA fragments were labeled with TAMRA-
dUTP (Applied Biosystems) in 20-ll reactions by either single or multiplex PCR
from plasmid DNA or aliquots of unlabeled PCR products obtained by an
intermediate amplification step. As a positive control, we included a DNA probe
labeled with biotin-dUTP (Roche) identifying locus D6Z1 on bovine
chromosome 6, which has been described in detail elsewhere [26]. Both the
TAMRA-labeled, transgene-specific fragments and the biotin-labeled control
probe were mixed, ethanol precipitated, and resuspended in hybridization buffer
(Dako, Glostrup, Denmark).
The probe DNA was denatured at 758C for 10 min and cooled on ice until
application. Chromosome preparations were denatured in 70% formamide/23
SSC, pH 7.0, at 708C, dehydrated in a series of increasingly concentrated
ethanol, and air dried before probe loading. Hybridization for 72–96 h at 378C
was followed by high-stringency washes for 2 3 5 min at 608C in 0.13 SSC.
Hybridization of the biotin-labeled positive control was detected by Avidin
Alexa Fluor 488 (Invitrogen). Chromosomes were counterstained with 40,60-
diamidino-2-phenylindole (DAPI) and mounted with Vectashield antifade
solution (Vector Laboratories, Burlingame, CA). Metaphase images were
captured using a confocal laser scanning microscope (LSM 510 Meta; Zeiss,
Göttingen, Germany) and a 633 PlanApochromat (numerical aperture 1.4) oil
immersion objective.
Somatic Cell Nuclear Transfer
The originally transfected BFF clones were used for first-round SCNT at
passages 9–11, and fibroblasts derived from transgenic fetuses were used at
passages 4–6 for second-round SCNT. The nuclear transfer procedure has been
described in detail previously [27]. Cloned embryos were cultured in 100-ll
drops of synthetic oviduct fluid supplemented with 5% (v/v) estrous cow serum








Whole-Mount Preparation of SCNT Embryos and Confocal
Laser Scanning Microscopy
EGFP expression of BFFGOF12 SCNT embryos was analyzed on Days 4
and 6. EGFP fluorescence was initially checked using an inverted epifluor-
escence microscope (Axiovert 200M; Zeiss) equipped with an appropriate
narrow bandpass filter set for excitation at 470/20 nm and emission at 505–530
nm (Zeiss). Digital images were taken with a 203 objective and a color CCD
camera (AxioCam HR; Zeiss). Subsequently, the embryos were fixed with 4%
(w/v) paraformaldehyde in PBS for 30 min, followed by washing with PBS
containing 1 mg/ml polyvinyl pyrrolidone. After staining the cell nuclei with 1
lg/ll Hoechst 33342 for 30 min, embryos were mounted in Vectashield antifade
solution on coverslips in such a way that the three-dimensional structure of the
specimen was maintained. Stacks of optical serial sections (optical thickness 1
lm) were recorded using a confocal laser scanning microscope (LSM 510 Meta;
Zeiss) with a 403 PlanApochromat (numerical aperture 1.3) oil immersion
objective. For excitation of Hoechst 33342 and EGFP, laser lines of 364 nm and
488 nm were used, respectively. The resulting fluorescence emissions were
detected through emission bandpass filters at 385–470 nm (Hoechst 33342) and
505–530 nm (EGFP). In addition, the emission spectrum of each embryo
obtained by excitation at 488 nm was analyzed and compared to the emission
spectrum of EGFP using a polychromatic multichannel detector (Meta detector;
Zeiss) to clearly differentiate EGFP fluorescence from autofluorescence.
The EGFP fluorescence intensity of individual embryos was assessed on
central optical sections, including all pixel intensity values of the total area
occupied by blastomeres. This was done using ImageJ software (National
Institutes of Health, Bethesda, MD). Median intensity values were used to
compare the EGFP fluorescence of individual embryos and to correlate it with
the number of cell nuclei. In each embryo we determined 1) the total number of
cell nuclei and 2) the number of decaying (i.e., fragmented, pyknotic, and
apoptotic) nuclei by comparing each optical serial section from bottom to top to
the subjacent section.
Whole-Mount RNA In Situ Hybridization
Localization of POU5F1 transcripts in SCNT bovine embryos was
performed as previously described [28]. For in vitro transcription of a
digoxigenin-labeled bovine POU5F1 mRNA-specific antisense riboprobe, a
517-nucleotide fragment (nucleotides 808–854, 1184–1342, and 1448–1755;
GenBank accession no. AF022987) was amplified from bovine blastocysts by
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RT-PCR and was subcloned into pCRII TOPO (Invitrogen, Carlsbad, CA). For
whole-mount in situ hybridization, embryos (Days 4, 6, and 7) were fixed in
4% paraformaldehyde/0.1% glutaraldehyde at room temperature for 30 min.
Fixed embryos were treated with 10 lg/ml proteinase K in PBS supplemented
with 10% Tween-20 (PBT) for 15 min at room temperature, and then with 2
mg/ml glycine in PBT for 10 min at room temperature. Prehybridization was
performed in hybridization solution (50% formamide; 53 SSC, pH 4.5; 0.1%
Tween-20; 50 lg/ml heparin) containing 100 lg/ml tRNA and 100 lg/ml
salmon sperm DNA for 2 h at 558C, and hybridization with riboprobe in
hybridization solution containing tRNA and salmon sperm DNA was
performed overnight at 588C. Stringent posthybridization washes were
performed three times for 20 min each in 23 SSC, pH 4.5; 50% formamide;
and 0.1% Tween-20 at 598C. After hybridization, embryos were incubated in
blocking solution (10 mM maleic acid, 15 mM NaCl, 1% blocking reagent
[Roche 11 096 176 001], and 2% sheep serum), and then were treated with
1:2000 anti-digoxigenin-AP Fab fragments (Roche 11 093 274 910) in
blocking solution overnight at 48C. After antibody treatment, embryos were
washed in a solution containing 10 mM maleic acid, 15 mM NaCl, 10%
Tween-20, and 2 mM levamisole to block endogenous alkaline phosphatase.
For color reaction, embryos were incubated in 1:50 NBT/BCIP Stock Solution
(Roche 1 681 451) in solution containing 100 mM NaCl, 100 mM Tris, 50 mM
MgCl
2
, 0.1% Tween-20, and 2 mM levamisole for 60–70 min at room
temperature. Embryos were washed and mounted in PBS containing 25 mM
EDTA and were observed under an inverted microscope.
Outgrowth Formation Assay
Mitomycin C-treated STO cells (feeder cells) were plated on gelatinized four-
well plates (23104 cells/well) in fibroblast cell culture medium (see above). Cells
were cultured at 378C in a humidified atmosphere of 5% CO
2
in air. Day 7 SCNT
embryos from cell clone BFFGOF12 were placed on the feeder cells and
incubated at 398C in a humidified atmosphere of 5% CO
2
in air until Day 15. The
culture medium was changed both before plating the embryos on the feeder cells
and on Day 13. Outgrowth formation was observed every other day.
Embryo Transfer and Derivation of Transgenic Fetal Fibroblasts
EGFP-positive Day 7 blastocysts were transferred to synchronized
recipients as described previously [24]. Pregnancy was diagnosed by
ultrasonography on Day 28. Pregnancies were terminated on Day 34 after
SCNT. The recovered fetuses were carefully examined for malformations and
subsequently processed to establish transgenic fetal fibroblast cultures [27]. In
brief, after removal of head, tail, and visceral organs, the remaining fetal tissue
was finely minced and dissociated with PBS containing 1.0 g/l trypsin and 0.4
g/l EDTA (PAA) for 7 min at 378C. The resulting cell suspension was washed
with cell culture medium (see above) and seeded on cell culture plates. Primary
cultures were grown for 7 days and cryopreserved in multiple aliquots.
RESULTS
Stable Transfection of BFFs with the GOF18-DPE-EGFP
Reporter Gene Construct
PCR screening of 113 BFF colonies resistant to the selection
antibiotic revealed a GOF18-DPE-EGFP-specific amplicon in
16 clones. As expected for differentiated somatic cells, none of
FIG. 1. A) The reporter gene construct GOF18-DPE-EGFP (21.2 kb),
which contains EGFP flanked by a 9-kb fragment of the murine Pou5f1
upstream region with a deletion in the proximal enhancer (PE) and a 9-kb
fragment containing the (nontranscribed) structural Pou5f1 gene. Exons
are represented by black boxes. The red boxes mark the target sites for the
transgene-specific FISH probe. B) FISH on metaphase spreads demon-
strating a single-locus integration of the reporter gene construct in cell
3
clone BFFGOF12 of transfected BFFs. The hybridization signal on the
GOF18-DPE-EGFP transgene (green) is indicated by an arrow. A FISH
probe identifying locus D6Z1 on bovine chromosome 6 (red, marked by
arrowheads) served as a control for hybridization efficiency. Bar¼ 10 lm.
C) In the transfected BFFGOF12 cells no EGFP fluorescence was
detectable (left, bright field; right, fluorescence image). The insets show
BFFs carrying a reporter gene driven by the PGK1 housekeeping gene
promoter; these were used as a positive control for EGFP detection. Bar¼
100 lm. D) Experimental design: fetal fibroblasts with a single-locus
integration of GOF18-DPE-EGFP but without detectable EGFP expression
were selected for first-round SCNT. Mouse Pou5f1 promoter-driven
expression of EGFP was analyzed in SCNT embryos on Days 4 and 6 by
confocal laser scanning microscopy (CLSM). Day 7 SCNT embryos were
used for in vitro outgrowth formation assay and embryo transfer. GOF18-
DPE-EGFP transgenic fibroblasts isolated from SCNT fetuses showed
silencing of the reporter gene construct and were used for second-round
SCNT.
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the fibroblast clones showed detectable (Pou5f1 promoter-
driven) EGFP expression (Fig. 1C). In a pilot experiment, six
of these clones were used for nuclear transfer, and the resulting
SCNT embryos were checked for EGFP fluorescence at the
morula or blastocyst stage. EGFP expression was observed in
cloned embryos from three of the six transfected BFF clones,
demonstrating that the mouse Pou5f1 promoter of the GOF18-
DPE-EGFP reporter gene construct could be activated in early
bovine SCNT embryos. The three BFF clones leading to
EGFP-expressing embryos were subjected to karyotyping and
transgene integration analysis by FISH. Cell clone BFFGOF12,
which had a normal karyotype (60, XX) and a single transgene
integration site, was chosen for studies on the reporter gene
expression in SCNT embryos (Fig. 1B).
Consistent Initiation of GOF18-DPE-EGFP Expression in
Bovine SCNT Embryos
In total, 200 nuclear transfers using the transfected clone
BFFGOF12 were performed in three independent experiments.
The fusion rate was 96% 6 1%. In each experiment, the
nuclear transfer complexes were randomly divided into two
groups for evaluation on Days 4 and 6. In total, 73 embryos
from Day 4 and 53 embryos from Day 6 were evaluated by
epifluorescence and confocal laser scanning microscopy.
True EGFP fluorescence was validated and clearly separated
from autofluorescence by analyzing the emission spectrum of
all Pou5f1-EGFP transgenic embryos and nontransgenic
control embryos at 488-nm excitation using a polychromatic
multichannel detector (supplemental Figure S1, available
online at www.biolreprod.org). Table 1 summarizes numbers
of nuclei and EGFP expression in Day 4 embryos. No EGFP
expression was detected in embryos with fewer than nine
nuclei, clearly indicating that the Pou5f1 promoter was not
active before passing the fourth cell division. A total of 9 of 13
embryos contained between 9 and 16 nuclei and exhibited
EGFP fluorescence in at least one or more blastomeres, some
of them with different fluorescence intensities among the
blastomeres. As a representative example, an SCNT embryo
with 12 blastomeres showing different levels of EGFP
expression is shown in Figure 2, A and A0.
Developmental Heterogeneity and Variable GOF18-DPE-
EGFP Expression in Day 6 SCNT Embryos
The morphology, the number of cell nuclei, and the level of
EGFP expression of Day 6 embryos varied in rather broad
ranges: 31 of 53 embryos evaluated on Day 6 had fewer than
nine nuclei and did not exhibit any EGFP expression.
However, EGFP fluorescence was unequivocally detected in
all Day 6 embryos with nine or more nuclei and was
considerably stronger than in Day 4 embryos (Fig. 2, B and
B0). Figure 3 (central diagram) shows the median fluorescence
intensity values assessed on central optical sections of embryos
plotted against the numbers of nuclei. There was no significant
correlation (r ¼ 0.34, P ¼ 0.12) between the median
fluorescence intensity and the number of nuclei. In general,
nuclei of embryos exhibiting high EGFP fluorescence (Fig. 3,
upper image panel) appeared to be more homogeneous in shape
and size compared with those of embryos with low EGFP
expression (Fig. 3, lower image panel). Therefore, we
compared the incidence of nuclear abnormalities (condensed/
fragmented nuclei) between SCNT embryos with high and low
EGFP fluorescence at similar cell numbers. Notably, embryos
with low EGFP expression exhibited a significantly higher
proportion (5.8%–9.4%; mean: 8.0%) of abnormal nuclei
TABLE 1. EGFP expression driven by the mouse Pou5f1 promoter in Day
4 bovine SCNT embryos from bovine fetal fibroblasts (cell clone
BFFGOF12).
No. of nuclei No. of embryos EGFP expression (%)
1–4 38 0
5–8 8 0
9–16 13 9 (69%)
17–30 14 14 (100%)
FIG. 2. Analysis of mouse Pou5f1 pro-
moter-driven EGFP expression in bovine
SCNT embryos by CLSM on Days 4 and 6.
Each horizontal panel shows single-channel
images of an optical section through the
center of a representative whole-mount
embryo. A–C) Transmission scan image (left)
and the cell nuclei stained with Hoechst
33342 (right). A0–C0) Linear intensity image
(left) and color-coded intensity map (right)
of EGFP fluorescence. A, A0) Day 4 embryo
with 12 nuclei: EGFP is detectable in all
blastomeres but at different levels in indi-
vidual blastomeres. A total of 9 of 13 Day 4
embryos with at least nine nuclei showed
EGFP fluorescence in at least one or more
blastomeres. No EGFP expression was
detected in embryos with fewer than eight
nuclei, indicating that the Pou5f1 promoter
was not activated before passing the fourth
cell division. B, B0) Highest EGFP fluores-
cence intensities were measured on Day 6
at the morula/blastocyst stage. C, C0) Neg-
ative control: nontransgenic Day 6 embryo
created by in vitro fertilization. Bar ¼ 100
lm.
986 WUENSCH ET AL.
FIG. 3. Analysis of mouse Pou5f1 pro-
moter-driven EGFP fluorescence intensity in
Day 6 SCNT embryos. Central diagram:
median intensity values determined on
central confocal optical sections are plotted
against nuclei numbers. Between the me-
dian fluorescence intensities and the em-
bryonic nuclei numbers a weak positive
correlation (r ¼ 0.34, P ¼ 0.12) was found.
In embryos with high EGFP expression
(values indicated by A–D) the proportion of
abnormal nuclei was very small and the cell
nuclei appeared more homogeneous in
shape and size compared with embryos
with a similar number of nuclei but low
EGFP expression (values indicated by E–H).
The upper and the lower image panels show
three embryos with high EGFP fluorescence
(denoted A, B, C) and three embryos with
low EGFP fluorescence (denoted E, F, and
G). The cell nuclei of the embryos was
stained with Hoechst 33342 and are dis-
played as maximum intensity projections of
confocal image stacks; EGFP expression is
demonstrated on central confocal sections.
The letters in the image panels refer to the
respective (identically noted) measured
values in the central diagram. Bar ¼
100 lm.
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compared with the embryos with high EGFP expression
(0.6%–5.0%; mean: 1.8%).
Expression of Endogenous POU5F1 mRNA in SCNT
Embryos
The presence of endogenous POU5F1 mRNA was
investigated by whole-mount in situ hybridization in 15 SCNT
embryos from Day 4, 26 SCNT embryos from Day 6, and 23
SCNT embryos from Day 7 (Fig. 4). POU5F1 mRNA signal
was detected in single Day 4 embryos. Increased signal
intensity was observed in all Day 6 and Day 7 embryos; some
50% exhibited POU5F1 mRNA expression only in the ICM,
whereas the remaining embryos showed a positive hybridiza-
tion signal in both ICM and trophectoderm (TE).
Outgrowth Formation In Vitro
To gain initial information on a potential correlation
between level of EGFP expression and the differentiation
potential of Pou5f1-EGFP transgenic SCNT embryos, we
performed in vitro outgrowth experiments on Day 7 blastocysts
shortly before or after hatching. In the experiments, nine
blastocysts were placed on feeder cells (STO cells) and were
cultured until Day 15. Two blastocysts, one hatched and one
nonhatched, showing low EGFP fluorescence did not form
outgrowths. One hatching and five hatched blastocysts with
medium to high EGFP expression attached to the feeder cells
and formed outgrowths. In one case, EGFP fluorescence was
detected in ICM outgrowth areas until Day 15 after SCNT; in
another case, it was detected until Day 13 (Fig. 5). One
blastocyst showing strong EGFP fluorescence did not hatch,
and thus could not form an outgrowth.
In Vivo Development of SCNT Embryos from BFFs Stably
Transfected with GOF18-DPE-EGFP and Second-Round
SCNT
Transfer of three Day 7 SCNT embryos (early blastocysts)
from the transfected clone BFFGOF12 into each of four
synchronized recipients resulted in one singleton and one twin
pregnancy, which were terminated on Day 34 after SCNT.
Three normally developed fetuses without detectable malfor-
mations were recovered (Fig. 6A). In fibroblast cultures from
the transgenic fetuses, EGFP fluorescence was not detected
(Fig. 6, B and C). Thus, the mouse Pou5f1 promoter was silent
in the differentiated somatic fetal cells. As in the originally
transfected cell clones, cytogenetic analysis revealed a normal
karyotype (60, XX) and a single chromosomal transgene
integration site (Fig. 6D). Fibroblasts derived from one
transgenic fetus (FeGOF451–1) were used for second-round
SCNT to determine whether the Pou5f1 promoter-driven
reporter gene was activated. Indeed, the GOF18-DPE-EGFP
reporter gene expression was initiated after SCNT (Fig. 6F).
FIG. 4. Analysis of endogenous POU5F1 transcripts in bovine SCNT
embryos derived from BFFGOF12 cells by whole-mount RNA in situ
hybridization. A–C) Hybridization of digoxigenin-labeled antisense RNA
probes was detected by NBT/BCIP color reaction. A) In Day 4 embryos,
low POU5F1 transcript levels were detected. Embryo on the right at a
more advanced stage of development showed a stronger signal than that
on the left. B, C) In Day 6 and Day 7 embryos, higher signal intensities
were observed. B) Prehatched (left) and hatching (right) Day 6 blastocyst
with high POU5F1 transcript levels in the ICM (arrow). C) Prehatched (left)
and hatching (right) Day 7 blastocyst with high POU5F1 transcript levels
in the ICM (arrow). Some 50% of Day 6 and Day 7 embryos showed
hybridization signals also in the trophectoderm (arrowhead). D) Negative
controls: Day 4 embryo (left) and Day 6 blastocyst (right) hybridized
without riboprobe.
FIG. 5. Outgrowth formation assay with BFFGOF12 SCNT embryos. A)
Day 13 embryo placed on feeder cells. Left: bright field; right:
fluorescence. B) Outgrowth formation on Day 15. Left: bright field; right:
fluorescence. Bar ¼ 100 lm.
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Notably, when compared to first-round SCNT embryos from
the originally transfected cell clone BFFGOF12, second-round
SCNT embryos from transgenic FeGOF451–1 fetal fibroblasts
developed to blastocysts at a significantly (P , 0.05) higher
rate (Table 2).
DISCUSSION
The marked differences in the efficiency of SCNT between
different mammalian species strongly suggest that in spite of a
probably conserved general principle, important aspects of
nuclear reprogramming are determined by species-specific
mechanisms. Potential factors include differences in the timing
of embryonic genome activation (reviewed in Memili and First
[29]) and in the temporal/spatial pattern of DNA methylation
and histone modifications [11, 30]. The present study used
activation of the ‘‘pluripotency’’ gene POU5F1 as an indicator
for nuclear reprogramming after SCNT in the bovine, the
species in which this technology currently has the highest
efficiency. To facilitate this analysis in living embryos, we
used nuclear donor cells with a stable single-site integration of
a Pou5f1-EGFP reporter gene.
EGFP fluorescence was not detected in embryos with fewer
than nine nuclei, but it was detected in all embryos with 16 or
more cells, indicating that the Pou5f1-EGFP reporter gene was
consistently activated between the third and fourth cell cycles.
In spite of the markedly lower efficiency of SCNT in the mouse,
activation of EGFP expression was observed in more than 80%
of embryos cloned from cumulus cells carrying the same
reporter gene [18]. However, EGFP expression started one cell
FIG. 6. In vivo development of SCNT
embryos from BFFs stably transfected with
GOF18-DPE-EGFP and EGFP expression in
second-round SCNT embryos. A) A 34-day-
old SCNT fetus from cell clone BFFGOF12.
In fibroblasts isolated from this fetus (line
FeGOF451–1), no EGFP fluorescence was
detectable: bright field (B) and fluorescence
(C) images. The mouse Pou5f1 promoter
had been effectively silenced in the differ-
entiated somatic fetal cells. D) FISH on
metaphase spreads confirmed the stable
single-locus integration of the reporter gene
construct in cells isolated from the SCNT
fetus. The hybridization signal on the
GOF18-DPE-EGFP transgene (green) is in-
dicated by an arrow. Red signals (marked by
arrowheads) indicate detection of locus
D6Z1 on bovine chromosome 6 as a control
for hybridization efficiency. Transgenic fi-
broblasts isolated from the SCNT fetus (line
FeGOF451–1) were used for second-round
SCNT. EGFP expression driven by the
mouse Pou5f1 promoter was again activat-
ed: stereomicroscopic (E) and fluorescence
(F) images from Day 7 embryos. Bar ¼ 6.5
mm (A), 10 lm (B–D), and 100 lm (E, F).
TABLE 2. Efficiency of first round SCNT using originally transfected fetal bovine fibroblasts (BFFGOF12) and second round SCNT using fibroblasts
isolated from a GOF18-DPE-EGFP transgenic fetus (FeGOF451–1).
Donor cells Experiments Oocytes (n) Fusion rate (%)c Cleavage rate (%)c,d Blastocyst rate (%)c,e
BFFGOF12a 4 161 93.7 6 2.6 87.8 6 4.8 24.7 6 8.5
FeGOF451–1b 3 113 95.5 6 4.0 61.5 6 10.0 39.8 6 4.4*
a Cells used at passages 9–11.
b Cells used at passages 4–5.
c Values are mean 6 SD.
d Rate is based on fused karyoplast-cytoplast complexes.
e Rate is based on cleaved embryos.
* Significantly different between the two donor cell types; P¼ 0.02.
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cycle earlier, between the four- and eight-cell stages, which is
consistent with the earlier maternal zygotic transition in mouse
compared to cattle (reviewed in Memili and First [29]).
Interestingly, a marked variation of EGFP fluorescence
intensity was observed in bovine embryos cloned from Pou5f1-
EGFP-transfected fibroblasts. Low fluorescence levels were
associated with an increased proportion of abnormal nuclei.
These observations indicate: 1) that further modulation of
pluripotency gene expression may occur after initial consistent
activation coincident with the major wave of maternal zygotic
transition, and 2) that low expression of pluripotency gene may
be associated with reduced developmental potential. An
association between POU5F1 expression and developmental
potential is supported by the lack of outgrowth formation from
blastocysts with low Pou5f1-EGFP expression.
A key finding in cloned mouse embryos was abnormal
spatial distribution of Pou5f1 mRNA in SCNT mouse
blastocysts, 55% of which showed Pou5f1 expression in both
the ICM and the TE. In contrast, ectopic localization of Pou5f1
transcripts in the TE was observed in only 11% of blastocysts
derived by in vitro fertilization and in 4% of in vivo-produced
embryos [18]. Our in situ hybridization studies of POU5F1
transcript localization in cloned bovine embryos revealed about
50% of embryos with POU5F1 mRNA signals in both the ICM
and the TE, whereas the other half of the cloned embryos
showed endogenous POU5F1 transcripts only in the ICM, as
was previously described for in vitro-produced bovine
blastocysts [28]. Thus, half of the bovine SCNT embryos
expressed POU5F1 transcripts in the TE, an expression pattern
that has been shown to be associated with the abnormal
development of cloned mouse embryos [18]. The consequences
of POU5F1 mRNA expression in the TE of bovine SCNT
blastocysts for further development are not clear. One potential
mechanism by which POU5F1 might affect TE cell function is
regulation of the expression of interferon tau (IFNT), the major
embryonic pregnancy recognition signal in ruminants [31].
Studies in human chorion carcinoma cells transfected with
IFNT1 promoter-luciferase reporter constructs revealed that
POU5F1 silences IFNT promoters by quenching ETS2 trans-
activation [32]. Thus, it will be interesting to compare the
levels of IFNT secretion by blastocysts with versus those
without POU5F1 expression in the TE, and to systematically
analyze maternal responses to these classes of embryos, such as
through holistic transcriptome [33, 34] and proteome studies
[35] of endometrium samples from pregnant recipients. It will
be of particular interest to study in detail the correlation
between the transcription level of POU5F1 and the expression
of CDX2 and its protein. Recent observations have provided
convincing evidence for an essential role of CDX2 protein in
the segregation of ICM and TE in mouse embryos by
repressing Pou5f1 and Nanog in the TE lineage cells [36].
In spite of similar proportions of POU5F1/Pou5f1 transcript
localization in the TE of bovine and mouse SCNT blastocysts,
the development in vivo was markedly different between the
two species. In our study in cattle, transfer of SCNT blastocysts
from Pou5f1-EGFP-transfected cells to four recipients resulted
in two pregnancies, and three (50%) of the six embryos in
pregnant recipients developed into apparently normal fetuses.
In mice, transfer of two-cell SCNT embryos from Pou5f1-
EGFP transgenic cumulus cells to recipients resulted in a
comparable pregnancy rate (24 [59%] of 41), but only 0.8% (7
of about 850) of two-cell embryos or about 11% of blastocysts
(9% blastocyst rate based on two-cell embryos) in pregnant
recipients developed into a fetus (Day 10 after conception;
[18]). Taken together, these findings indicate that the presence
of POU5F1/Pou5f1 mRNA in the TE of cloned blastocysts
does not explain the marked difference in the efficiency of
SCNT between mouse and cattle.
Careful examination of the three SCNT fetuses derived from
Pou5f1-EGFP-transfected fibroblasts (BFFGOF12) at low
magnification revealed that they were free of malformations
and were appropriately developed for the gestational age.
EGFP expression was not detectable, demonstrating that the
mouse Pou5f1 promoter was silent in differentiated cells.
However, Pou5f1-EGFP transgenic fibroblasts isolated from
these fetuses could be reprogrammed to express EGFP by a
second round of nuclear transfer. This further confirmed that
Pou5f1-EGFP transgenic fetuses are a valuable source of cells
to systematically investigate epigenetic reprogramming of
different cell types, either by in vitro systems or by SCNT.
Interestingly, the rate of development to blastocyst was higher
in second-round SCNT using transgenic fetal fibroblasts than it
was in first-round SCNT experiments from Pou5f1-EGFP-
transfected fibroblasts. This observation indicates that trans-
fection and selection procedures may negatively affect the
potential of donor fibroblasts for SCNT, but the underlying
changes can be rescued during the development of a cloned
fetus, which provided transgenic nuclear donor cells with a
higher developmental potential.
An interesting application of Pou5f1-EGFP transgenic
cloned blastocysts may be the derivation of pluripotent stem
cells in the bovine. Many attempts to derive pluripotent
embryonic stem (ES) cells in the bovine have resulted thus far
only in ES-like cells, which are characterized by the expression
of certain marker genes and by in vitro differentiation properties
(reviewed in Prelle et al. [37]). Two studies produced chimeric
animals, demonstrating the differentiation potential of bovine
ES-like cells in vivo [38, 39]; however, contribution to the
germline was not shown. Our in vitro outgrowth experiments
demonstrated continuous EGFP expression in some of the
outgrowths from Pou5f1-EGFP SCNT embryos. Future studies
need to clarify whether these cells provide a superior source for
the derivation of pluripotent cell lines.
In summary, we showed that Pou5f1-EGFP transgenic
fibroblasts with a single chromosomal integration site are a
suitable model to monitor Pou5f1 promoter activation in
bovine SCNT embryos. We demonstrated that virtually all
SCNT embryos developing beyond the 16-cell stage activated
the Pou5f1 promoter. However, the level of Pou5f1-EGFP
expression was highly variable between individual embryos.
Moreover, we obtained considerable evidence that the level of
Pou5f1-EGFP expression is associated with parameters of
embryo quality and viability, such as the proportion of
abnormal cell nuclei and the ability to form outgrowths in
vitro. Chromosomally and phenotypically normal fetuses with
a stable single locus insertion of the Pou5f1-EGFP reporter
gene construct permitting activation and silencing of the
Pou5f1 promoter provide cells, in which the initiation of
epigenetic reprogramming can be observed in the living state.
Such cells represent a strategic tool to answer a broad range of
important questions in bovine development and embryo
biotechnology, such as 1) reprogramming of different cell
types after nuclear transfer, 2) the correlation between gene
activation or silencing and changes in chromatin domain
organization or nuclear architecture, and 3) the isolation of
pluripotent stem cells.
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